McKesson, J&J eye GHX platform for e-pedigree

E-commerce service provider Global Healthcare Exchange (GHX) is looking for drug manufacturers, wholesalers and retailers willing to test the data exchange system it hopes will become the underpinning of a supply-chain-wide traceability and e-pedigree solution for the pharma industry. Presenters at the recent HDMA Track and Trace Seminar provided reasons to move forward with the project, according to a report in Pharmaceutical Commerce.

GHX's existing e-commerce platform already links some 12,000 healthcare trading partners, noted a speaker from Big 3 distributor McKesson ($MCK). The system works despite varying levels of transaction complexity across supply chain partners, according to the report. A Johnson & Johnson ($JNJ) speaker noted the test gives participants a chance to see how GS1 standards could work, providing some insight into upcoming IT needs and changes in business practices.  

GHX began testing the system--a GS1-compliant data exchange that will hold supply chain transaction records and make them accessible for verification--with the aid of industry collaborators earlier this year. The project became operational in October 2011 with the transmission, storage and retrieval of actual track/trace data, according to the report. GHX intends the system to be compatible with evolving FDA and industry standards.

GHX's goal now is to stress-test the system by increasing the number of participating supply chain partners, the report said.

- see the story  

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.